Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2010
04/06/2010US7691848 10-[(2,2'-Dimethyl-1,1'-biphenyl-4-yl)carbonyl]-N-(3-methoxybenzyl)-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide; antifertility agents
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2546192C Pyrrolopyrimidine compounds useful in treatment of cancer
04/06/2010CA2468801C Hydroxycucurbituril derivatives, their preparation methods and uses
04/06/2010CA2462506C Compositions, methods and kits pertaining to luminescent compounds
04/06/2010CA2351709C Novel triazolo(4,5-d)pyrimidine compounds
04/01/2010WO2010036404A2 Novel retinamide retinoic acid metabolism blocking agents
04/01/2010WO2010036362A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010034996A1 Crystalline acid addition salts and their use as enzyme inhibitors
04/01/2010WO2010034838A2 New chemical compounds
04/01/2010WO2010034740A1 (r)-3-(n,n-dimethylamino)pyrrolidine derivatives
04/01/2010WO2010015849A3 Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
04/01/2010WO2010005195A3 Method for preparing crystal form l of adefovir dipivoxil
04/01/2010WO2009142842A3 Novel macrocyclic inhibitors of hepatitis c virus replication
04/01/2010WO2009131669A3 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/01/2010US20100081683 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
04/01/2010US20100081676 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same
04/01/2010US20100081662 Pyrrolotriazine kinase inhibitors
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081655 Reverse-turn mimetics and method relating thereto
04/01/2010US20100081647 Short-acting benzodiazepine salts and their polymorphic forms
04/01/2010US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
04/01/2010CA2738448A1 New chemical compounds
04/01/2010CA2737031A1 Indole and indoline derivatives and methods of use thereof
04/01/2010CA2736880A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
03/2010
03/31/2010EP2168968A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
03/31/2010EP2168967A1 Intermediates for preparation of an inhibitor of phosphodiesterase type 5
03/31/2010EP2168966A1 Bicycloaniline derivative
03/31/2010EP2167502A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
03/31/2010EP2167482A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
03/31/2010EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor
03/31/2010EP2167465A1 Indolinone derivatives and their use in treating disease-states such as cancer
03/31/2010EP2166856A1 Chemical compounds
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP1765823B1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/31/2010EP1756111B1 Alkyl substituted indoloquinoxalines
03/31/2010EP1756110B1 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT
03/31/2010EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010EP1362382B1 Aryl-aryl dendrimers having a metalloporphyrine core
03/31/2010CN101687887A Tricyclic nitrogen containing compounds as antibacterial agents
03/31/2010CN101687876A amino-heterocyclic compounds
03/31/2010CN101687875A Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
03/31/2010CN101687874A Pyrrolotriazine kinase inhibitors
03/31/2010CN101687873A Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
03/31/2010CN101687872A Solid forms of pemetrexed
03/31/2010CN101687869A Heterocyclic compounds useful as MK2 inhibitors
03/31/2010CN101687866A Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
03/31/2010CN101687865A A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
03/31/2010CN101687827A aminodihydrothiazine derivatives substituted with cyclic groups
03/31/2010CN101687792A Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
03/31/2010CN101686981A diazo bicyclic smac mimetics and the uses thereof
03/31/2010CN101684122A Polymer norbornane compound and synthetic method thereof
03/31/2010CN101684121A New crystal form of pemetrexed diacid and method for preparing same
03/31/2010CN101684118A Use of tricyclic compounds as glycine transport inhibitors
03/31/2010CN101684101A Piperazinone substituted tetracycline derivatives
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687623 2,2,2-Trichloro-1-{10-[(2'-methoxy-1,1'-biphenyl-4-yl)carbonyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl}ethanone; reacting a tricyclic diazepine with diphosgene and a primary or secondary amine
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687507 Protein tyrosine kinase, such as Janus Kinase 3, inhibitors, immunosuppressants; organ transplants, lupus, multiple sclerosis, psoriasis; antidiabetic agents, antiarthritic agents, anticarcinogenic agents, Alzheimer's Disease, Crohn's Disease, Inflammatory Bowel Disease, autoimmune thyroid disorders
03/30/2010US7687506 Selective serine/threonine kinase inhibitors
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687086 Method for obtaining taxanes
03/30/2010CA2577525C Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/25/2010WO2010033981A2 5-azaindole bisphosphonates
03/25/2010WO2010032264A2 Improved process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine & new impurities in preparation thereof
03/25/2010WO2010032200A1 Amide compounds useful in therapy
03/25/2010WO2010032195A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
03/25/2010WO2010031816A1 3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
03/25/2010WO2010031357A1 New crystalline forms of pemetrexed diacid, and preparations thereof
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076046 Antiviral Indoles
03/25/2010US20100075999 Process for the Preparation of Ethyl-N-(2,3-Dichloro-6-Nitrobenzyl)Glycine Hydrochloride
03/25/2010US20100075998 Tricyclic indoles and (4,5-dihydro) indoles
03/25/2010US20100075996 Pyrrolo[2,3-d]pyrimidine compounds
03/25/2010US20100075993 Small molecule inhibitors against west nile virus replication
03/25/2010US20100075965 Pi3 kinase inhibitors and methods of their use
03/25/2010US20100075958 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/25/2010US20100075955 Short-acting benzodiazepine salts and their polymorphic forms
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075952 Pyrrolo-nitrogenous heterocyclic derivaties,the preparation and the pharmcetical use theeof
03/25/2010US20100075945 Gram-positive carbapenem antibacterials and processes for their preparation
03/25/2010US20100075911 Dimeric iap inhibitors
03/25/2010CA2737967A1 New crystalline forms of pemetrexed diacid, and preparations thereof
03/25/2010CA2735931A1 Amide compounds useful in therapy
03/24/2010EP2166011A1 Compound for organic electroluminescent device and organic electroluminescent device
03/24/2010EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/24/2010EP2164851A1 Porphyrin and conductive polymer compositions for use in solid-state electronic devices
03/24/2010EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010EP1789404B1 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
03/24/2010EP1745047B1 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine adenosine-a2a- receptor antagonists
03/24/2010CN101679448A spiroindolinone derivatives
03/24/2010CN101679447A pyrimidodiazepinone derivative
03/24/2010CN101679446A 3,3-spiroindolinone derivatives
03/24/2010CN101679445A Pyrimidinedione derivatives and methods of use thereof
03/24/2010CN101679444A Xanthine compounds having a positive allosteric gabab receptor modulator effect
03/24/2010CN101679443A Heterocyclically substituted heterocyclyl carboxylic acid derivatives
03/24/2010CN101679442A Compounds for the treatment of hepatitis c
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 573